大脑神经血管表观基因组及其与痴呆症的关联
Kevin Chris Ziegler1, Aydan Askarova1, Charbel Gergian1
1UK Dementia Research Institute, Imperial College London, London, UK; Department of Brain Sciences, Imperial College London, London, UK.
Neuron
|October 31, 2025
概括
这项研究探讨了阿尔茨海默病 (AD) 和大脑小血管疾病 (SVD) 中的大脑细胞表观基因组. 它确定了两种疾病的神经血管系统内的独特的遗传风险路径和潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 大脑小血管疾病 (SVD) 经常与阿尔茨海默病 (AD) 一起发生.
- 大脑内皮细胞 (BECs) 与AD遗传风险有关,但它们的表观基因组和与遗传风险因素的相互作用是未知的.
- 神经血管单元在SVD和AD病原体中的作用需要进一步调查.
研究的目的:
- 研究人类大脑内皮细胞 (BEC) 和其他神经血管细胞的表观基因组.
- 探索细胞表观基因组与阿尔茨海默病 (AD) 和脑小血管疾病 (SVD) 的遗传风险因素的交叉.
- 确定疾病特异性的调节机制和神经血管系统中的潜在治疗点.
主要方法:
- 为人类BECs,壁画细胞和其他脑细胞类型生成基因规律组.
- 对增强剂与基因相互作用的分析,以确定与疾病相关的基因.
- 针对特定途径的化合物的in silico选.
主要成果:
- 阿尔茨海默氏病 (AD) 的遗传性主要与某些脑内皮细胞 (BEC) 丰富有关,与免疫相关.
- 大脑小血管疾病 (SVD) 的遗传性在整个神经血管单元中得到丰富,包括星球细胞.
- 显著的增强剂到基因网络涉及阿米洛伊德/脂路径在AD和老化在SVD.
- 微质和BEC中的转录因子图案对AD和SVD变体进行了丰富.
- 在体查中确定了潜在的治疗化合物,包括维生素D受体激活剂和mTOR,HDAC和VEGFR抑制剂.
结论:
- 这项研究揭示了神经血管系统内的AD和SVD的独特表观基因组景观和遗传风险路径.
- 这些发现突显了特定细胞类型 (如BEC和星球细胞) 在这些神经系统疾病中的作用.
- 已确定的调节机制和治疗点为治疗AD和SVD提供了新的途径.
相关概念视频
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Dementia
508
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
508
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
The Blood-brain Barrier
52.2K
Overview
52.2K
Neurogenesis and Regeneration of Nervous Tissue
1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K
Disorders of the Nervous Tissue
2.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.5K


